LOCALLY ADVANCED CERVICAL CANCER
Clinical trials for LOCALLY ADVANCED CERVICAL CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED CERVICAL CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED CERVICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shrink tumors before cervical cancer surgery
Disease control OngoingThis study is testing whether adding a new immunotherapy drug called QL1706 to standard chemotherapy before surgery works better for treating locally advanced cervical cancer. About 54 participants will receive the drug combination for three cycles, followed by surgery. Researche…
Matched conditions: LOCALLY ADVANCED CERVICAL CANCER
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug tested to keep aggressive cervical cancer at bay
Disease control OngoingThis study is testing whether an immunotherapy drug called volrustomig can help prevent cancer from returning in women with high-risk cervical cancer. Participants are women whose cancer hasn't progressed after completing standard chemotherapy and radiation treatment. The goal is…
Matched conditions: LOCALLY ADVANCED CERVICAL CANCER
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC